The Federal Food, Drug and Cosmetic
Act of 35 U.S.C. 156 pemits the USPTO to restore the patent term
lost due to certain types of regulatory review by the Federal Food
and Drug Administration or the Department of Agriculture. Only
patents for drug products medical devices, food additives, and
color additives are eligible for an extension. Under 35 U.S.C. 154
the USPTO may also in some cases adjust the term if an original
patent due to delays in the prosecution of the application. The
information in this collec- tion is used by the USPTO to consider
whether an application is eligible for a patent term extension or
reconsideration of.......
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.